Sickle Cell Disease in the GCC: AI Documentation for a High-Prevalence Condition

Category: Clinical Workflow & Specialty Guides | Market: GCC | Keywords: GCC sickle cell disease AI documentation high prevalence haematology

Sickle cell disease (SCD) is among the most prevalent genetic conditions in the GCC, with particularly high rates in Saudi Arabia's Eastern Province (where sickle cell trait carrier rates exceed 25% in some communities), the UAE, Oman, Bahrain, and Kuwait. The Gulf states have invested significantly in national sickle cell programmes — newborn screening, comprehensive SCD centres, and disease-modifying therapy access — and the longitudinal documentation demands of comprehensive SCD management are substantial. AI medical scribing is enabling GCC haematologists and SCD clinic physicians to maintain complete, consistent clinical records across a lifetime of specialist care.

## The GCC Sickle Cell Programme

Saudi Arabia's National Premarital Screening Programme, which includes SCD carrier testing, has been mandatory since 2004 and is one of the most successful genetic disease prevention programmes in the region. Despite this, the existing SCD patient population is large — Saudi Arabia alone manages several thousand SCD patients. UAE, Oman, and Bahrain have similarly active SCD national programmes with dedicated clinical centres. Comprehensive SCD care involves haematology, paediatrics transitioning to adult care, pulmonology, nephrology, ophthalmology, and orthopaedics — generating multidisciplinary documentation demands.

## SCD Clinic Documentation Requirements

• Steady-state haematological review: haemoglobin (Hb), reticulocyte count, HbF percentage, LDH, bilirubin — with comparison to the patient's personal baseline and trend documentation.

• Pain history: frequency, severity, location, and management of vaso-occlusive crises since last visit — with the pattern of crisis frequency over time documented to guide hydroxyurea therapy decisions.

• Organ system review: pulmonary (acute chest syndrome history, SpO2, spirometry), renal (eGFR, proteinuria trend), neurological (silent cerebral infarction history, TCD velocities), retinal screening status, and avascular necrosis assessment.

• Hydroxyurea therapy management: current dose, HbF response, tolerability, and dose optimisation documentation.

• Transfusion programme documentation: for patients on chronic transfusion (typically for stroke prevention) — haemoglobin S percentage, ferritin, chelation therapy, and transfusion record.

## Acute Vaso-Occlusive Crisis Documentation

ED presentation record. Acute SCD crisis documentation in the emergency department — pain severity, hydration, opioid requirements, and the clinical decision on admission or discharge — is time-sensitive and benefits from AI scribing capturing the full assessment accurately.

Acute chest syndrome documentation. Acute chest syndrome — the most dangerous acute complication of SCD — requires specific clinical documentation of oxygen saturation trend, chest X-ray findings, management with blood transfusion and respiratory support, and the monitoring plan. This documentation is medicolegally critical.

Opioid management records. SCD acute pain management frequently involves significant opioid doses. Complete documentation of opioid prescribing, dosing rationale, and pain response assessment — captured by AI scribing — supports both clinical quality and opioid governance compliance.

## Paediatric-to-Adult Transition Documentation

Transitioning adolescent SCD patients from paediatric to adult haematology services is a high-risk period for care quality. Comprehensive transition documentation — complete medical history summary, organ complication inventory, current management plan, and psychosocial context — generated by AI scribing from the paediatric SCD record supports safe and complete handover to the adult SCD team.

## Conclusion

GCC sickle cell disease services managing one of the world's most concentrated SCD patient populations across dedicated national programmes benefit substantially from AI medical scribing. Complete longitudinal clinic notes capturing haematological parameters, organ system monitoring, crisis history, and disease-modifying therapy management — generated efficiently from clinical encounters — improve documentation quality and continuity of care across the lifetime of specialist management that SCD requires. AI scribing is an essential documentation tool for GCC SCD services committed to internationally benchmarked comprehensive care.

Internal links: Genetics Rare Disease Saudi Arabia AI Notes Complex Genetic Cases, Haematology Saudi Arabia AI Notes Blood Disorders, Paediatrics UAE Polyclinics AI Scribe Child Visits, ICU Documentation GCC Hospitals AI Critical Care